Primary Site >> Stomach Cancer

Gene >> YY1AP1

  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Functional genomics identified a novel protein tyrosine phosphatase receptor type F-mediated growth inhibition in hepatocarcinogenesis.
PMID: 24470239
Ref: VGLL4 inhibits EMT in part through suppressing Wnt/beta-catenin signaling pathway in gastric cancer.
PMID: 25701461
Ref: miR-222/VGLL4/YAP-TEAD1 regulatory loop promotes proliferation and invasion of gastric cancer cells.
PMID: 26045994
Ref: Optimum 3D Matrix Stiffness for Maintenance of Cancer Stem Cells Is Dependent on Tissue Origin of Cancer Cells.
PMID: 26168187
Ref: RUNX3 is a novel negative regulator of oncogenic TEAD-YAP complex in gastric cancer.
PMID: 26364597
Ref: Fat4 suppression induces Yap translocation accounting for the promoted proliferation and migration of gastric cancer cells.
PMID: 26575609
Ref: Loss of large tumor suppressor 1 promotes growth and metastasis of gastric cancer cells through upregulation of the YAP signaling.
PMID: 26921249
Ref: CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma.
PMID: 27105510
Ref: Roles of RUNX in Hippo Pathway Signaling.
PMID: 28299672
Ref: DNA-binding mechanism of the Hippo pathway transcription factor TEAD4.
PMID: 28368398
Ref: Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
PMID: 29402328
Ref: VGLL4 is a transcriptional cofactor acting as a novel tumor suppressor via interacting with TEADs.
PMID: 30034932
Ref: PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
PMID: 30134988